One place. Endless possibilities.
|
NasdaqGM: DEPO Stock Quote
NasdaqGM: DEPO Overview
Depomed, Inc. (Depomed) is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. It has developed two products, which have been approved by the Food & Drug Administration (FDA) and are marketed. GLUMETZA is a once-daily treatment for adults with type 2 diabetes that the Company commercialize in the United States with Santarus, Inc. (Santarus). Proquin XR (ciprofloxacin hydrochloride) is a once-daily treatment for uncomplicated urinary tract infections.
|
|
|||||||||||||||||||||||||||||||||||||||||
Do you know of another great research resource for DEPO that belongs here? Please let us know and provide the URL.